Evenness skin tone | |||||
0 = not even at all; 10 = very even | |||||
| Variations Δ | ||||
Sub# | D0 | D28 | D56 | D28 | D56 |
1 | 4 | 5 | 5 | 1 | 1 |
2 | 4 | 5 | 4 | 1 | 0 |
3 | 4 | 4 | 5 | 0 | 1 |
4 | 5 | 6 | 6 | 1 | 1 |
5 | 4 | 5 | 5 | 1 | 1 |
6 | 4 | 5 | 4 | 1 | 0 |
7 | 5 | 6 | 5 | 1 | 0 |
8 | 3 | 4 | 4 | 1 | 1 |
9 | 3 | 4 | 4 | 1 | 1 |
10 | 4 | 5 | 5 | 1 | 1 |
11 | 6 | 7 | 7 | 1 | 1 |
12 | 5 | 6 | 6 | 1 | 1 |
13 | 5 | 6 | 6 | 1 | 1 |
14 | 4 | 5 | 5 | 1 | 1 |
15 | 6 | 6 | UN | 0 | UN |
16 | 3 | 4 | 3 | 1 | 0 |
17 | 5 | 6 | 6 | 1 | 1 |
18 | 5 | 6 | 6 | 1 | 1 |
19 | 6 | 6 | 7 | 0 | 1 |
20 | 7 | NC | 8 | NC | 1 |
21 | 3 | 5 | 4 | 2 | 1 |
22 | 6 | 6 | 7 | 0 | 1 |
Mean | 4.6 | 5.3 | 5.3 | 0.9 | 0.8 |
Med | 4.5 | 5.0 | 5.0 | 1.0 | 1.0 |
Min | 3.0 | 4.0 | 3.0 | 0.0 | 0.0 |
Max | 7.0 | 7.0 | 8.0 | 2.0 | 1.0 |
SEM | 0.2 | 0.2 | 0.3 | 0.1 | 0.1 |
95% CI | 0.5 | 0.4 | 0.6 | 0.2 | 0.2 |
# of subjects | 22 | 21 | 21 | 21 | 21 |
| Δ % | 16% | 16% | ||
Statistical analysis p = | <0.0001 | <0.0001 | |||
Statistical test | Wilcoxon signed rank test | Wilcoxon signed rank test | |||
% of subjects presenting an improvement | 81% | 81% | |||
% of subjects without change | 19% | 19% | |||
% of subjects presenting worsening | 0% | 0% | |||
Brightness/complexion radiance | |||||
0 = dull complexion; 10 = radiant/luminous complexion | |||||
| Variations Δ | ||||
Sub# | D0 | D28 | D56 | D28 | D56 |
1 | 3 | 4 | 4 | 1 | 1 |
2 | 5 | 6 | 5 | 1 | 0 |
3 | 3 | 4 | 4 | 1 | 1 |
4 | 4 | 5 | 5 | 1 | 1 |
5 | 4 | 5 | 5 | 1 | 1 |
6 | 3 | 4 | 3 | 1 | 0 |
7 | 5 | 5 | 6 | 0 | 1 |
8 | 3 | 3 | 4 | 0 | 1 |
9 | 3 | 4 | 4 | 1 | 1 |
10 | 4 | 5 | 5 | 1 | 1 |
11 | 6 | 7 | 7 | 1 | 1 |
12 | 5 | 5 | 6 | 0 | 1 |
13 | 5 | 6 | 6 | 1 | 1 |
14 | 4 | 5 | 5 | 1 | 1 |
15 | 4 | 4 | UN | 0 | UN |
16 | 3 | 4 | 4 | 1 | 1 |
17 | 4 | 5 | 5 | 1 | 1 |
18 | 5 | 5 | 6 | 0 | 1 |
19 | 6 | 6 | 7 | 0 | 1 |
20 | 6 | NC | 7 | NC | 1 |
21 | 4 | 6 | 5 | 2 | 1 |
22 | 6 | 6 | 7 | 0 | 1 |
Mean | 4.3 | 5.0 | 5.2 | 0.7 | 0.9 |
Med | 4.0 | 5.0 | 5.0 | 1.0 | 1.0 |
Min | 3.0 | 3.0 | 3.0 | 0.0 | 0.0 |
Max | 6.0 | 7.0 | 7.0 | 2.0 | 1.0 |
SEM | 0.2 | 0.2 | 0.3 | 0.1 | 0.1 |
95% CI | 0.5 | 0.4 | 0.5 | 0.3 | 0.1 |
# of subjects | 22 | 21 | 21 | 21 | 21 |
| Δ % | 15% | 21% | ||
Statistical analysis p = | 0.0001 | <0.0001 | |||
Statistical test | Wilcoxon signed rank test | Wilcoxon signed rank test | |||
% of subjects presenting an improvement | 67% | 90% | |||
% of subjects without change | 33% | 10% | |||
% of subjects presenting worsening | 0% | 0% | |||
Skin texture/Fineness of the skin texture | |||||
0 = coarse; 10 = fine | |||||
| Variations Δ | ||||
Sub# | D0 | D28 | D56 | D28 | D56 |
1 | 4 | 4 | 5 | 0 | 1 |
2 | 4 | 5 | 5 | 1 | 1 |
3 | 4 | 4 | 5 | 0 | 1 |
4 | 4 | 5 | 5 | 1 | 1 |
5 | 4 | 4 | 5 | 0 | 1 |
6 | 4 | 4 | 5 | 0 | 1 |
7 | 5 | 6 | 6 | 1 | 1 |
8 | 3 | 3 | 4 | 0 | 1 |
9 | 3 | 4 | 4 | 1 | 1 |
10 | 5 | 5 | 6 | 0 | 1 |
11 | 6 | 6 | 7 | 0 | 1 |
12 | 5 | 5 | 6 | 0 | 1 |
13 | 5 | 6 | 7 | 1 | 2 |
14 | 3 | 4 | 4 | 1 | 1 |
15 | 5 | 5 | UN | 0 | UN |
16 | 2 | 3 | 3 | 1 | 1 |
17 | 5 | 6 | 6 | 1 | 1 |
18 | 5 | 6 | 7 | 1 | 2 |
19 | 6 | 6 | 7 | 0 | 1 |
20 | 6 | NC | 7 | NC | 1 |
21 | 4 | 6 | 5 | 2 | 1 |
22 | 6 | 6 | 7 | 0 | 1 |
Mean | 4.5 | 4.9 | 5.5 | 0.5 | 1.1 |
Med | 4.5 | 5.0 | 5.0 | 0.0 | 1.0 |
Min | 2.0 | 3.0 | 3.0 | 0.0 | 1.0 |
Max | 6.0 | 6.0 | 7.0 | 2.0 | 2.0 |
SEM | 0.2 | 0.2 | 0.3 | 0.1 | 0.1 |
95% CI | 0.5 | 0.5 | 0.6 | 0.3 | 0.1 |
# of subjects | 22 | 21 | 21 | 21 | 21 |
| Δ % | 10% | 24% | ||
Statistical analysis p = | 0.0020 | <0.0001 | |||
Statistical test | Wilcoxon signed rank test | Wilcoxon signed rank test | |||
% of subjects presenting an improvement | 48% | 100% | |||
% of subjects without change | 52% | 0% | |||
% of subjects presenting worsening | 0% | 0% | |||
RADIANCE EFFECT (average grade) Note: a compilation of the three grades is performed. A significant increase of the average grade allows to conclude a radiance effect (if no worsening is observed on the separately taken scores). | |||||
| Variations Δ | ||||
Sub# | D0 | D28 | D56 | D28 | D56 |
1 | 3.7 | 4.3 | 4.7 | 0.7 | 1.0 |
2 | 4.3 | 5.3 | 4.7 | 1.0 | 0.3 |
3 | 3.7 | 4.0 | 4.7 | 0.3 | 1.0 |
4 | 4.3 | 5.3 | 5.3 | 1.0 | 1.0 |
5 | 4.0 | 4.7 | 5.0 | 0.7 | 1.0 |
6 | 3.7 | 4.3 | 4.0 | 0.7 | 0.3 |
7 | 5.0 | 5.7 | 5.7 | 0.7 | 0.7 |
8 | 3.0 | 3.3 | 4.0 | 0.3 | 1.0 |
9 | 3.0 | 4.0 | 4.0 | 1.0 | 1.0 |
10 | 4.3 | 5.0 | 5.3 | 0.7 | 1.0 |
11 | 6.0 | 6.7 | 7.0 | 0.7 | 1.0 |
12 | 5.0 | 5.3 | 6.0 | 0.3 | 1.0 |
13 | 5.0 | 6.0 | 6.3 | 1.0 | 1.3 |
14 | 3.7 | 4.7 | 4.7 | 1.0 | 1.0 |
15 | 5.0 | 5.0 | UN | 0.0 | UN |
16 | 2.7 | 3.7 | 3.3 | 1.0 | 0.7 |
17 | 4.7 | 5.7 | 5.7 | 1.0 | 1.0 |
18 | 5.0 | 5.7 | 6.3 | 0.7 | 1.3 |
19 | 6.0 | 6.0 | 7.0 | 0.0 | 1.0 |
20 | 6.3 | NC | 7.3 | NC | 1.0 |
21 | 3.7 | 5.7 | 4.7 | 2.0 | 1.0 |
22 | 6.0 | 6.0 | 7.0 | 0.0 | 1.0 |
Mean | 4.5 | 5.1 | 5.4 | 0.7 | 0.9 |
Med | 4.3 | 5.3 | 5.3 | 0.7 | 1.0 |
Min | 2.7 | 3.3 | 3.3 | 0.0 | 0.3 |
Max | 6.3 | 6.7 | 7.3 | 2.0 | 1.3 |
SEM | 0.2 | 0.2 | 0.3 | 0.1 | 0.1 |
95% CI | 0.5 | 0.4 | 0.5 | 0.2 | 0.1 |
# of subjects | 22 | 21 | 21 | 21 | 21 |
| D% | 14% | 20% | ||
| Statistical analysis p = | <0.0001 | <0.0001 | ||
| Statistical test | paired t-test | Wilcoxon signed rank test | ||
% of subjects presenting an improvement | 86% | 100% | |||
% of subjects without change | 14% | 0% | |||
% of subjects presenting worsening | 0% | 0% |